You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

WELLCOVORIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Wellcovorin patents expire, and when can generic versions of Wellcovorin launch?

Wellcovorin is a drug marketed by Glaxosmithkline and is included in five NDAs.

The generic ingredient in WELLCOVORIN is leucovorin calcium. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the leucovorin calcium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Wellcovorin

A generic version of WELLCOVORIN was approved as leucovorin calcium by HIKMA on September 14th, 1987.

  Try a Trial

Drug patent expirations by year for WELLCOVORIN
Recent Clinical Trials for WELLCOVORIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mayo ClinicPhase 1
Arcus Biosciences, Inc.Phase 1/Phase 2
Jonsson Comprehensive Cancer CenterPhase 1/Phase 2

See all WELLCOVORIN clinical trials

US Patents and Regulatory Information for WELLCOVORIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline WELLCOVORIN leucovorin calcium INJECTABLE;INJECTION 087439-001 Oct 19, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glaxosmithkline WELLCOVORIN leucovorin calcium INJECTABLE;INJECTION 089834-001 Jan 23, 1989 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glaxosmithkline WELLCOVORIN leucovorin calcium INJECTABLE;INJECTION 089833-001 Jan 23, 1989 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glaxosmithkline WELLCOVORIN leucovorin calcium INJECTABLE;INJECTION 089465-001 Jan 23, 1989 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.